遗传拯救模型反驳了色素性视网膜炎中非自主性视杆细胞死亡。
Genetic rescue models refute nonautonomous rod cell death in retinitis pigmentosa.
机构信息
Jonas Children's Vision Care, Departments of Ophthalmology, Pathology, and Cell Biology, Columbia University, New York, NY 10032.
Bernard & Shirlee Brown Glaucoma Laboratory, Departments of Ophthalmology, Pathology, and Cell Biology, Columbia University, New York, NY 10032.
出版信息
Proc Natl Acad Sci U S A. 2017 May 16;114(20):5259-5264. doi: 10.1073/pnas.1615394114. Epub 2017 May 3.
Retinitis pigmentosa (RP) is an inherited neurodegenerative disease, in which the death of mutant rod photoreceptors leads secondarily to the non-cell autonomous death of cone photoreceptors. Gene therapy is a promising treatment strategy. Unfortunately, current methods of gene delivery treat only a fraction of diseased cells, yielding retinas that are a mosaic of treated and untreated rods, as well as cones. In this study, we created two RP mouse models to test whether dying, untreated rods negatively impact treated, rescued rods. In one model, treated and untreated rods were segregated. In the second model, treated and untreated rods were diffusely intermixed, and their ratio was controlled to achieve low-, medium-, or high-efficiency rescue. Analysis of these mosaic retinas demonstrated that rescued rods (and cones) survive, even when they are greatly outnumbered by dying photoreceptors. On the other hand, the rescued photoreceptors did exhibit long-term defects in their outer segments (OSs), which were less severe when more photoreceptors were treated. In summary, our study suggests that even low-efficiency gene therapy may achieve stable survival of rescued photoreceptors in RP patients, albeit with OS dysgenesis.
色素性视网膜炎(RP)是一种遗传性神经退行性疾病,其中突变的杆状光感受器的死亡导致其次是锥状光感受器的非细胞自主死亡。基因治疗是一种很有前途的治疗策略。不幸的是,目前的基因传递方法只能治疗一部分病变细胞,导致视网膜呈现出治疗和未治疗的杆状细胞以及锥状细胞的马赛克。在这项研究中,我们创建了两种 RP 小鼠模型,以测试死亡的、未治疗的杆状细胞是否会对治疗的、挽救的杆状细胞产生负面影响。在一种模型中,治疗和未治疗的杆状细胞被分开。在第二种模型中,治疗和未治疗的杆状细胞被广泛混合,并且它们的比例被控制以实现低、中或高效的挽救。对这些嵌合体视网膜的分析表明,即使在大量死亡的光感受器中,挽救的杆状细胞(和锥状细胞)仍然存活。另一方面,挽救的光感受器在外节(OS)中确实表现出长期缺陷,当更多的光感受器被治疗时,这些缺陷的严重程度较轻。总之,我们的研究表明,即使是低效的基因治疗也可能在 RP 患者中实现挽救的光感受器的稳定存活,尽管存在 OS 发育不良。